Hypersensitive site 2 located in the f-globin locus control region confers high levels of expression to the genes of the 1-globin cluster. A tandem repeat of the consensus sequence for the transcription factors AP1 and NF-E2 (acti- 
vating protein 1 and nuclear factor erythroid 2, respectively) is present within hypersensitive site 2 and Is absolutely required for strong enhancer activity. This sequence binds, in vitro and in vivo, to ubiquitous proteins of the AP1 family and to the recently cloned erythroid-specific transcription factor NF-E2. Using the tandem repeat as a recognition site probe to screen a Agtll cDNA expression library from K562 cells, we isolated several DNA binding proteins. Here, we report the characterization of one of the clones Isolated. The gene, which we named Nrf2 (NF-E2-related factor 2), is encoded within a 2.2-kb transcript and predicts a 66-kDa protein with a basic leucine zipper DNA binding domain highiy homologous to that of NF-E2. Although Nrf2 is expressed ubiquitously, a role of this protein in mediating enhancer activity of hypersensitive site 2 in erythroid cells cannot be excluded. In this respect, Nrf2 contains a powerful acidic activation domain that may participate in the transcriptional stimulation of 3globin genes.
In the last decade the recognition and characterization of a locus control region (LCR) in the 5' region of the 3-globin gene cluster (1-3) have greatly advanced our understanding of globin gene regulation. The LCR contains four DNase I hypersensitive sites (HSs) and is responsible for the tissueand stage-specific regulation of the individual globin genes. Since its discovery, numerous experiments have been carried out, especially in transgenic mouse models (4) (5) (6) (7) (8) (9) , to investigate which DNA sequences within the individual HSs are essential for directing high levels ofglobin gene expression in the erythroid tissues. The results of such experiments in combination with transfection studies (10) (11) (12) and DNAprotein interaction analysis (4, (13) (14) (15) have pinpointed several conserved sequence elements dispersed along the four HSs that are critical for the LCR function. These elements are binding sites for ubiquitous and erythroid-specific transcription factors, such as GT binding protein, GATA-1 (16) , and NF-E2 (nuclear factor erythroid 2) (17, 18) , that are likely to modulate the action of the RNA polymerase over the globin gene promoters. GATA-1 was the first erythroidspecific transcription factor to be cloned and extensively studied. Recently, the cloning of NF-E2 (19) , which is believed to mediate most ofthe enhancer activity ofthe LCR, has been accomplished. NF-E2 is one of the proteins that bind to the tandem AP1 (activating protein 1)-NF-E2 repeat, which represents the core enhancer within HS2 (4, 11, 12) .
We screened a hemin-induced K562 cDNA library in Agtll by using the tandem AP1-NF-E2 repeat as a recognition site probe. Among the several clones that we isolated, two had remarkable similarities with NF-E2. One of them was identical to the recently described Nrfl (NF-E2-related factor 1) transcription factor (20) . The other is another factor hereafter referred to as Nrf2 (NF-E2-related factor 2, previously HEBP1), in agreement with the nomenclature adopted by Chan et al. (20) . Like NF-E2, Nrf2 binds to the AP1-NF-E2 tandem repeat of HS2, belongs to the same family of basic leucine zipper (bZIP) transcription factors, and is a powerful activator of the RNA polymerase II. Protein sequence comparison demonstrates several regions of remarkable similarity between Nrf2 and NF-E2. The relatedness of Nr2, NF-E2, and Nrf1 is further demonstrated by (i) the similarities in their genomic organization and (ii) the homologies of the genetic loci of their respective chromosomal locations (42) . The cloning of yet another member of the NF-E2 family of transcription factors adds further complexity to the interpretation of the role played by any of these factors in the regulation of the globin gene expression. (25) . The Gal4-Nrf2 construct used in the transactivation assay was made by fusing in-frame, in the pSG424 vector (26) , residues 1-327 of Nrt2 activation domain with residues 1-147 of Gal4 DNA binding domain. The positive control Gal4-VP16 (27) Tissue Expression. Northern blot analyses were done with mRNA derived from human cell lines and tissues (Fig. 4 ). Nrf2 appears to be expressed almost ubiquitously although at different levels in different tissues. Muscle, kidney, and lung in the adult and liver and muscle in the fetus were among the highest in Nrt2 expression. Thus the pattern of expression resembles Nrfl more than that of NF-E2, which appears to be more restricted to the hematopoietic tissues. We (Fig. 5) . We compared the activity of the Gal4-Nrf2 chimera with a reference chimera of Gal4 and VP16 (Gal4-VP16), the strong activator ofthe herpes simplex virus, one of the strongest known stimulators of RNA polymerase II transcription (27) of similarity can be tentatively established linking the four proteins in an evolutionary tree in the order cnc > Nrfl > Nrf2 > NF-E2. The cnc homology region is unlikely to participate in direct DNA binding, but its conservation in all members of the NF-E2 family suggests an important functional role. A homology search in the protein data base, using this region, did not show homology with other known protein motifs. No homology is apparent between Nrf2 and NF-E2 in the activation domains, the former being rich in acidic and serine residues and the latter being rich in proline residues. Limiting the analysis to the amino acid content, the activation domain of Nrf2 is more similar to Nrfl than to NF-E2.
MATERIALS AND METHODS
A closer look at the leucine-zipper region reveals that in the predicted coiled coil (residues 505-544), Nrf2 has the hydrophobic heptad repeats of leucines interrupted by a polar asparagine residue in the d position. Among the bZIP proteins, this is an unusual feature that could potentially hinder homodimer formation. In the EMBL transcription factors database, an asparagine in the leucine zipper was found only in the yeast AP1 transcription factor (36) . We expect this residue to be important in deter the specificity of heterodimerization for its propensity to establish a polar bond with a residue of opposite charge in the Ieucine zipper ofa yet unknown partner. Similar to the oncogene product Fos (37), a helical wheel representation of Nrf2 reveals that amino acids in the a position that interact with amino acids in the d position of the partner subunit display two charged lysine residues that can potentially destabilize homodimerization between the two molecules.
Despite the strong binding of Nrf2, when assayed on nitrocellulose filter, no binding was detected in solution using lysates from bacterial lysogens of the original phage clones, with an in vitro-synthesized full-length Nrf2 protein, or with crude extracts from COS cells transfected with an eukaryotic expression vector of the Nrt2 cDNA (data not shown). Binding on the filter appears to be not dependent on homodimerization through the leucine-zipper motif since the Nrf2 primary clone contained only a single heptad of the leucine dimerization domain, which is insufficient for dimer association. In addition, the structural analysis of the coiled coil predicted by the amino acid sequence in the leucinezipper domain (Fig. 6 ) reveals that Nrt2 has in the a position charged residues that would impede the dimer formation as it has been suggested for Fos (38, 39) , NF-E2, and Nrfl (20) . (40) . As the maf-related transcription factors are also organized into a family of several members (41), it will be interesting to see whether the associated partner for Nrfl and Nrf2 also belong to the v-maf family.
In contrast to NF-E2, the expression of Nrf2 is not restricted to the hematopoietic tissues (12, 20) (Fig. 4) The addition of this member to the NF-E2 family raises the question as to which protein mediates the enhancing activity in HS2. All members of the family are highly expressed in erythroid tissues such as fetal liver and in erythroid cell lines such as K562 and, therefore, could potentially bind and compete for the same sites within the LCR. In previous expression studies (11) using mutants of the tandem NF-E2-AP1 repeat of HS2, we have shown that the enhancer function was decreased by mutations in the 5' repeat, which is a perfect consensus sequence for NF-E2, but was completely abolished by an additional point mutation in the 3' repeat, which slightly diverges from the NF-E2 consensus and is, therefore, more likely to bind proteins different from NF-E2 such as Nrfl and/or Nrf2. On the other hand in this paper, we report that Nrf2 is a strong activator of RNA polymerase II, when assayed in COS cells. Preliminary transactivation experiments in an erythroid environment, such as the one provided by hemin-induced K562 cells, suggest that Nrfl and NrQ2 are at least as powerful as NF-E2 in stimulating a 'y-globin promoter bearing a single tandem AP1-NF-E2 repeat (data not shown).
The availability of the clones for NF-E2, Nrfl, and Nrf2 allows knock-out experiments in mice that can assess their roles in the regulation of the globin gene expression. However, multiple knock-out experiments may be necessary to obtain a mutant phenotype in the mouse, as these factors might be functionally redundant. Finally, a more complete picture of the function of this family of genes will require the isolation of the partners for Nrfl and NrM.
